APA

Mittendorf E., Ardavanis A., Symanowski J., Murray L., Litton J. & Hale D. F.Primary analysis of a prospective, randomized, single-blinded phase 11 trial evaluating the HER2 peptide AE37 vaccine in breast cancer patienrs to prevent recurrence. : .

Chicago

Mittendorf EA, Ardavanis A, Symanowski J, Murray L, Litton Jk and Hale D F.Primary analysis of a prospective, randomized, single-blinded phase 11 trial evaluating the HER2 peptide AE37 vaccine in breast cancer patienrs to prevent recurrence. : .

Harvard

Mittendorf E., Ardavanis A., Symanowski J., Murray L., Litton J. and Hale D. F.Primary analysis of a prospective, randomized, single-blinded phase 11 trial evaluating the HER2 peptide AE37 vaccine in breast cancer patienrs to prevent recurrence. : .

MLA

Mittendorf EA, Ardavanis A, Symanowski J, Murray L, Litton Jk and Hale D F.: . .